• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Zhongchao Inc.

    8/22/25 8:00:26 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate
    Get the next $ZCMD alert in real time by email
    6-K 1 ea0254052-6k_zhongchao.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of August 2025

     

    Commission File Number: 001-39229

     

    ZHONGCHAO INC.

    (Exact name of registrant as specified in its charter)

     

    Room 2504, OOCL Tower

    841 Yan’an Middle Road

    Jing’An District, Shanghai, China 200040

    Tel: 021-32205987

    (Address of Principal Executive Office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F  ☒      Form 40-F  ☐

     

     

     

     

     

     

    Adoption of 2025 Equity Incentive Plan

     

    On August 4, 2025, the board of directors of Zhongchao Inc. (the “Company”) approved the adoption of the Company’s 2025 Equity Incentive Plan (the “2025 Plan”), which became effective on the same day. The 2025 Plan provides for discretionary grants of, among the others, options, share appreciation right, restricted shares, restricted share units, performance units and performance shares to employees, directors and consultants of the Company. The number of ordinary shares that may be issued under the 2025 Plan is limited to 10,000,000 shares to be increased on the first trading day of each calendar year of the Company beginning on the first trading day in January 2026, by an amount equal to 2.0% of the total number of issued and outstanding ordinary shares as of the last trading day in the immediately preceding calendar year. Notwithstanding, the aggregate maximum number of ordinary shares that may be issue under the Plan is 50,000,000 shares.

     

    Copy of the 2025 Plan is being furnished as Exhibit 4.1 with this Current Report on Form 6-K. The foregoing description of the 2025 Plan does not purport to be complete and is subject to, and is qualified in its entirety by, the full text of the 2025 Plan.

     

    As a foreign private issuer, we are permitted, in lieu of certain requirements of the NASDAQ Stock Market Marketplace Rules (the “Nasdaq Rules”) and subject to certain exceptions, to follow the practices of our home country, which for the purpose of such rules is the Cayman Islands, pursuant to the home country rule exemption set forth under Nasdaq Rules 5615(a)(3).

     

    We elected to be exempt from the requirements under Nasdaq Rules 5635. Nasdaq Rules 5635 generally provides that shareholder approval is required prior to issuance (or potential issuance) of securities in relation to (i) the acquisition of the stock or assets of another company; (ii) equity-based compensation of officers, directors, employees or consultants; (iii) a change of control; and (iv) transactions other than public offerings whereby there is a 20% Issuance at a price that is less than the Minimum Price, as defined in Nasdaq Rules 5635(d). Our Cayman Islands counsel, Ogier, has provided a letter to Nasdaq certifying that under Cayman Islands law and our amended and restated memorandum and articles of association, we are not prohibited from issuing securities without first obtaining shareholder approval where such issuance of securities otherwise requires shareholder approval under Nasdaq Rules 5635.

     

    INCORPORATION BY REFERENCE

     

    This report on Form 6-K is hereby incorporated by reference in the registration statements of the Company on Form F-3 (No. 333-279667) and Form F-3 (No. 333-283916) to the extent not superseded by documents or reports subsequently filed or furnished.

     

    EXHIBIT INDEX

     

    Exhibit No.   Description
    4.1   Zhongchao Inc. 2025 Equity Incentive Plan

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      

      Zhongchao Inc.
         
    Date: August 22, 2025 By: /s/ Weiguang Yang
        Weiguang Yang
        Chief Executive Officer

     

     

    2

     

     

    Get the next $ZCMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZCMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZCMD
    SEC Filings

    View All

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    2/10/26 4:00:40 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    1/27/26 5:15:28 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    1/20/26 5:20:41 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    $ZCMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

    SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE) and reduced their financial challenges associated with long-term treatment. SLE is a chronic inflammatory autoimmune disease that affects multipl

    3/12/24 8:30:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    Zhongchao Inc. Announces 1-for-10 Share Consolidation

    SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that an extraordinary general meeting of shareholders held on Tuesday, February 20, 2024, approved the proposed 1-for-10 share consolidation of the Company's ordinary shares of US$0.0001 par value each (the "Share Consolidation"). Beginning with the opening of trading on February 29, 2024, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD", but under a new CUSIP num

    2/27/24 8:00:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

    SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its service agreement (the "Agreement") with Beijing Public Health Foundation ("BPHF"), a non-profit organization dedicated to enhancing Chinese citizens' health through public welfare initiatives and aid programs. Pursuant to the Agreement, Zhongxin and BPHF extended its par

    12/11/23 8:00:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    $ZCMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by ZHONGCHAO INC. (Amendment)

    SC 13D/A - Zhongchao Inc. (0001785566) (Subject)

    5/21/21 5:10:06 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate